varenicline has been researched along with Head and Neck Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conlon, MSC; Davidson, SM; Meigs, ML; Mispel-Beyer, K; Santi, SA; Saunders, DP | 1 |
| Ahluwalia, JS; Hatsukami, DK; Khariwala, SS; Nelson, HH; Nollen, N; Rubin, N; Stepanov, I | 1 |
2 other study(ies) available for varenicline and Head and Neck Neoplasms
| Article | Year |
|---|---|
Rates of Smoking Cessation at 6 and 12 Months after a Clinical Tobacco Smoking Cessation Intervention in Head and Neck Cancer Patients in Northern Ontario, Canada.
Topics: Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Nicotiana; Ontario; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
"Cold turkey" or pharmacotherapy: Examination of tobacco cessation methods tried among smokers prior to developing head and neck cancer.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cross-Sectional Studies; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Smoking Cessation Agents; Time Factors; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |